| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Assessment of Type I Error Rates for the Statistical Sub-model in NONMEM
|
Wählby, Ulrika
|
|
2002
|
29 |
3 |
p. 251-269
|
artikel
|
| 2 |
Assessment of Type I Error Rates for the Statistical Sub-model in NONMEM
|
Ulrika Wählby
|
|
2002
|
29 |
3 |
p. 251-269
19 p.
|
artikel
|
| 3 |
Bayesian Analysis of Population PK/PD Models: General Concepts and Software
|
Lunn, David J.
|
|
2002
|
29 |
3 |
p. 271-307
|
artikel
|
| 4 |
Bayesian Analysis of Population PK/PD Models: General Concepts and Software
|
David J. Lunn
|
|
2002
|
29 |
3 |
p. 271-307
37 p.
|
artikel
|
| 5 |
Errata: Ways to Fit a PK Model with Some Data Below the Quantification Limit, Stuart L. Beal, J. Pharmacokin. Pharmacodyn.28:481–504 (2001)
|
|
|
2002
|
29 |
3 |
p. 309
|
artikel
|
| 6 |
Errata: Ways to Fit a PK Model with Some Data Below the Quantification Limit, Stuart L. Beal, J. Pharmacokin. Pharmacodyn.28:481504 (2001)
|
|
|
2002
|
29 |
3 |
p. 309-309
1 p.
|
artikel
|
| 7 |
Mechanism-Based Pharmacodynamic Modeling of the Interaction of Midazolam, Bretazenil, and Zolpidem with Ethanol
|
Tuk, Bert
|
|
2002
|
29 |
3 |
p. 235-250
|
artikel
|
| 8 |
Mechanism-Based Pharmacodynamic Modeling of the Interaction of Midazolam, Bretazenil, and Zolpidem with Ethanol
|
Bert Tuk
|
|
2002
|
29 |
3 |
p. 235-250
16 p.
|
artikel
|
| 9 |
Pharmacokinetic Modeling of Arsenite Uptake and Metabolism in Hepatocytes—Mechanistic Insights and Implications for Further Experiments
|
Easterling, Michael R.
|
|
2002
|
29 |
3 |
p. 207-234
|
artikel
|
| 10 |
Pharmacokinetic Modeling of Arsenite Uptake and Metabolism in HepatocytesMechanistic Insights and Implications for Further Experiments
|
Michael R. Easterling
|
|
2002
|
29 |
3 |
p. 207-234
28 p.
|
artikel
|
Tijdschrift beschrijving